[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BioSpace [@biospace](/creator/twitter/biospace) on x 25.1K followers Created: 2025-07-22 17:08:59 UTC BMO Capital Markets pointed to FDA leadership, and CBER Director Vinay Prasad in particular, as potential factors in the agency’s decision to issue a complete response letter for Replimmune’s viral treatment RP1 for advanced melanomas. Shares of the company tumbled XX% on Tuesday. #FDA #CBER #biospace XXX engagements  **Related Topics** [stocks](/topic/stocks) [mergers and acquisitions](/topic/mergers-and-acquisitions) [Post Link](https://x.com/biospace/status/1947705446082531613)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioSpace @biospace on x 25.1K followers
Created: 2025-07-22 17:08:59 UTC
BMO Capital Markets pointed to FDA leadership, and CBER Director Vinay Prasad in particular, as potential factors in the agency’s decision to issue a complete response letter for Replimmune’s viral treatment RP1 for advanced melanomas. Shares of the company tumbled XX% on Tuesday.
#FDA #CBER #biospace
XXX engagements
Related Topics stocks mergers and acquisitions
/post/tweet::1947705446082531613